Perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma: DANTE, a randomized, open-label phase II trial of the German Gastric Group of the AIO and the SAKK
作者
S-E. Al-Batran,Claudia Pauligk,Ralf‐Dieter Hofheinz,Sylvie Lorenzen,Andreas N. WICKI,Alexander Siebenhuener,Michael Schenk,Peter C Thuss-Patience,Albrecht Kretzschmar,Claus Bolling,Ekkehard Eigendorff,Stefan Angermeier,Daniel Pink,Michael Geißler,Eray Goekkurt,Harald Schmalenberg,Lisa Waberer,Jonathan Talbot,Thorsten Oliver Goetze,Nils Homann